person · Reporting owner
McMurry-Heath Michelle
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Bioventus Inc.BVS · Entity 4996 | Director | June 02, 2026 | June 04, 2026 |
| REVVITY, INC.RVTY · Entity 3382 | Director | May 07, 2026 | May 11, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Bioventus Inc.
Report date June 02, 2026 · Filed June 04, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 77,279 |
Reported balance
After 2026-06-02 transaction · row 1
1 source rowRow 1 · 2026-06-02 · Exercise / conversion · Acquired 32,282 · Balance 77,279 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-06-02 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-06-02 · Exercise / conversion · Disposed 32,282 · Balance 0 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock. F2: The RSUs vested on June 2, 2026. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 25,146 |
Reported balance
After 2026-06-03 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-06-03 · Grant · Acquired 25,146 · Balance 25,146 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock. F3: The RSUs shall vest and become exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first Annual Meeting of Stockholders following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock.
F2: The RSUs vested on June 2, 2026.
F3: The RSUs shall vest and become exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first Annual Meeting of Stockholders following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date.
REVVITY, INC.
Report date May 07, 2026 · Filed May 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 6,513 |
Ending reported balance
After 2026-05-07 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-05-07 · Grant · Acquired 1,015 · Balance 5,248 F1: The Reporting Person was granted restricted stock units, with each unit representing a contingent right to receive one share of the issuer's common stock. The grant of restricted stock units will fully vest on April 27, 2027, the scheduled date for the issuer's next annual meeting of shareholders, subject to the Reporting Person's continued service through such date or, if earlier, upon the Reporting Person's death, disability or qualifying retirement, or the termination of the Reporting Person's service within 12 months following a change in control. Row 2 · 2026-05-07 · Grant · Acquired 1,265 · Balance 6,513 |
Filing footnotes · ownership attribution and instrument terms
F1: The Reporting Person was granted restricted stock units, with each unit representing a contingent right to receive one share of the issuer's common stock. The grant of restricted stock units will fully vest on April 27, 2027, the scheduled date for the issuer's next annual meeting of shareholders, subject to the Reporting Person's continued service through such date or, if earlier, upon the Reporting Person's death, disability or qualifying retirement, or the termination of the Reporting Person's service within 12 months following a change in control.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 03, 2026 Filed Jun 4, 2026 20:47 UTC | Bioventus Inc. BVS · Entity 4996 | GrantRestricted Stock Units · Derivative | 25,146 | $0.00 | $0.00 |
DisclosureSEC source: 0001904156-26-000004 · wk-form4_1780606021.xml · derivative · entry 3 McMurry-Heath Michelle · CIK 0001904156 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,146 Underlying: Class A Common Stock · 25,146 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock. F3 · derivative.exercise_date: The RSUs shall vest and become exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first Annual Meeting of Stockholders following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date. F3 · derivative.expiration_date: The RSUs shall vest and become exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first Annual Meeting of Stockholders following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date. Read SEC document |
| June 02, 2026 Filed Jun 4, 2026 20:47 UTC | Bioventus Inc. BVS · Entity 4996 | Exercise / conversionRestricted Stock Units · Derivative | 32,282 | $0.00 | $0.00 |
DisclosureSEC source: 0001904156-26-000004 · wk-form4_1780606021.xml · derivative · entry 2 McMurry-Heath Michelle · CIK 0001904156 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 32,282 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The RSUs vested on June 2, 2026. F2 · derivative.expiration_date: The RSUs vested on June 2, 2026. Read SEC document |
| June 02, 2026 Filed Jun 4, 2026 20:47 UTC | Bioventus Inc. BVS · Entity 4996 | Exercise / conversionClass A Common Stock | 32,282 | $0.00 | $0.00 |
DisclosureSEC source: 0001904156-26-000004 · wk-form4_1780606021.xml · nonDerivative · entry 1 McMurry-Heath Michelle · CIK 0001904156 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,279 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 07, 2026 Filed May 11, 2026 20:05 UTC | REVVITY, INC. RVTY · Entity 3382 | GrantCommon Stock | 1,265 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-216726 · ownership.xml · nonDerivative · entry 2 McMurry-Heath Michelle · CIK 0001904156 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,513 Read SEC document |
| May 07, 2026 Filed May 11, 2026 20:05 UTC | REVVITY, INC. RVTY · Entity 3382 | GrantCommon Stock | 1,015 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-216726 · ownership.xml · nonDerivative · entry 1 McMurry-Heath Michelle · CIK 0001904156 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,248 F1 · shares: The Reporting Person was granted restricted stock units, with each unit representing a contingent right to receive one share of the issuer's common stock. The grant of restricted stock units will fully vest on April 27, 2027, the scheduled date for the issuer's next annual meeting of shareholders, subject to the Reporting Person's continued service through such date or, if earlier, upon the Reporting Person's death, disability or qualifying retirement, or the termination of the Reporting Person's service within 12 months following a change in control. Read SEC document |
| March 11, 2026 Filed Mar 13, 2026 21:26 UTC | Bioventus Inc. BVS · Entity 4996 | SaleClass A Common Stock | 12,000 | $8.79 | $105,439.20 |
DisclosureSEC source: 0001904156-26-000002 · wk-form4_1773437199.xml · nonDerivative · entry 1 McMurry-Heath Michelle · CIK 0001904156 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,997 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $8.73 to $8.81, inclusive. Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| February 23, 2026 Filed Feb 25, 2026 21:05 UTC | REVVITY, INC. RVTY · Entity 3382 | SaleCommon Stock | 600 | $97.26 | $58,356.00 |
DisclosureSEC source: 0001193125-26-071522 · ownership.xml · nonDerivative · entry 1 McMurry-Heath Michelle · CIK 0001904156 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,233 F1 · price: The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $97.15 to $97.35. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| November 07, 2025 Filed Nov 10, 2025 22:08 UTC | Bioventus Inc. BVS · Entity 4996 | SaleClass A Common Stock | 17,701 | $7.42 | $131,254.69 |
DisclosureSEC source: 0001904156-25-000004 · wk-form4_1762812528.xml · nonDerivative · entry 1 McMurry-Heath Michelle · CIK 0001904156 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,997 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $7.36 to $7.43, inclusive. Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 03, 2025 Filed Jun 5, 2025 01:30 UTC | Bioventus Inc. BVS · Entity 4996 | GrantRestricted Stock Units · Derivative | 32,282 | $0.00 | $0.00 |
DisclosureSEC source: 0001578563-25-000306 · wk-form4_1749087005.xml · derivative · entry 3 McMurry-Heath Michelle · CIK 0001904156 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,282 Underlying: Class A Common Stock · 32,282 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock. F3 · derivative.exercise_date: The RSUs shall vest and become exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first Annual Meeting of Stockholders following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date. F3 · derivative.expiration_date: The RSUs shall vest and become exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first Annual Meeting of Stockholders following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date. Read SEC document |
| June 02, 2025 Filed Jun 5, 2025 01:30 UTC | Bioventus Inc. BVS · Entity 4996 | Exercise / conversionRestricted Stock Units · Derivative | 26,493 | $0.00 | $0.00 |
DisclosureSEC source: 0001578563-25-000306 · wk-form4_1749087005.xml · derivative · entry 2 McMurry-Heath Michelle · CIK 0001904156 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 26,493 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The RSUs vested on June 2, 2025. F2 · derivative.expiration_date: The RSUs vested on June 2, 2025. Read SEC document |
| June 02, 2025 Filed Jun 5, 2025 01:30 UTC | Bioventus Inc. BVS · Entity 4996 | Exercise / conversionClass A Common Stock | 26,493 | $0.00 | $0.00 |
DisclosureSEC source: 0001578563-25-000306 · wk-form4_1749087005.xml · nonDerivative · entry 1 McMurry-Heath Michelle · CIK 0001904156 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,698 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 29, 2025 Filed May 30, 2025 20:06 UTC | REVVITY, INC. RVTY · Entity 3382 | SaleCommon Stock | 600 | $92.17 | $55,299.00 |
DisclosureSEC source: 0000950170-25-079707 · ownership.xml · nonDerivative · entry 1 McMurry-Heath Michelle · CIK 0001904156 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,833 Read SEC document |
| April 30, 2025 Filed May 1, 2025 20:05 UTC | REVVITY, INC. RVTY · Entity 3382 | GrantCommon Stock | 1,338 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-061825 · ownership.xml · nonDerivative · entry 2 McMurry-Heath Michelle · CIK 0001904156 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,433 Read SEC document |
| April 30, 2025 Filed May 1, 2025 20:05 UTC | REVVITY, INC. RVTY · Entity 3382 | GrantCommon Stock | 1,074 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-061825 · ownership.xml · nonDerivative · entry 1 McMurry-Heath Michelle · CIK 0001904156 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,095 F1 · shares: The Reporting Person was granted restricted stock units, with each unit representing a contingent right to receive one share of the issuer's common stock. The grant of restricted stock units will fully vest on April 28, 2026, the scheduled date for the issuer's next annual meeting of shareholders, subject to the Reporting Person's continued service through such date or, if earlier, upon the Reporting Person's death, disability or qualifying retirement, or the termination of the Reporting Person's service within 12 months following a change in control. Read SEC document |
| February 06, 2025 Filed Feb 7, 2025 21:05 UTC | REVVITY, INC. RVTY · Entity 3382 | SaleCommon Stock | 1,970 | $119.49 | $235,395.30 |
DisclosureSEC source: 0000950170-25-016257 · ownership.xml · nonDerivative · entry 1 McMurry-Heath Michelle · CIK 0001904156 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,021 Read SEC document |
| June 16, 2024 Filed Jun 18, 2024 21:44 UTC | Bioventus Inc. BVS · Entity 4996 | Exercise / conversionRestricted Stock Units · Derivative | 386 | $0.00 | $0.00 |
DisclosureSEC source: 0001578563-24-000306 · wk-form4_1718747057.xml · derivative · entry 2 McMurry-Heath Michelle · CIK 0001904156 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 386 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The 386 RSUs vested on June 16, 2024. F2 · derivative.expiration_date: The 386 RSUs vested on June 16, 2024. Read SEC document |
| June 16, 2024 Filed Jun 18, 2024 21:44 UTC | Bioventus Inc. BVS · Entity 4996 | Exercise / conversionClass A Common Stock | 386 | $0.00 | $0.00 |
DisclosureSEC source: 0001578563-24-000306 · wk-form4_1718747057.xml · nonDerivative · entry 1 McMurry-Heath Michelle · CIK 0001904156 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,205 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 11, 2024 Filed Jun 13, 2024 21:26 UTC | Bioventus Inc. BVS · Entity 4996 | GrantRestricted Stock Units · Derivative | 26,493 | $0.00 | $0.00 |
DisclosureSEC source: 0001578563-24-000287 · wk-form4_1718313998.xml · derivative · entry 1 McMurry-Heath Michelle · CIK 0001904156 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,493 Underlying: Class A Common Stock · 26,493 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The RSUs shall vest and become exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first Annual Meeting of Stockholders following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date. F2 · derivative.expiration_date: The RSUs shall vest and become exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first Annual Meeting of Stockholders following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date. Read SEC document |
| June 07, 2024 Filed Jun 12, 2024 00:44 UTC | Bioventus Inc. BVS · Entity 4996 | Exercise / conversionRestricted Stock Units · Derivative | 30,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001578563-24-000266 · wk-form4_1718153041.xml · derivative · entry 2 McMurry-Heath Michelle · CIK 0001904156 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 30,400 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The RSUs vested on June 7, 2024. F2 · derivative.expiration_date: The RSUs vested on June 7, 2024. Read SEC document |
| June 07, 2024 Filed Jun 12, 2024 00:44 UTC | Bioventus Inc. BVS · Entity 4996 | Exercise / conversionClass A Common Stock | 30,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001578563-24-000266 · wk-form4_1718153041.xml · nonDerivative · entry 1 McMurry-Heath Michelle · CIK 0001904156 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,819 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 01, 2024 Filed May 2, 2024 20:05 UTC | REVVITY, INC. RVTY · Entity 3382 | GrantCommon Stock | 1,218 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-052072 · ownership.xml · nonDerivative · entry 2 McMurry-Heath Michelle · CIK 0001904156 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,991 Read SEC document |
| May 01, 2024 Filed May 2, 2024 20:05 UTC | REVVITY, INC. RVTY · Entity 3382 | GrantCommon Stock | 977 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-052072 · ownership.xml · nonDerivative · entry 1 McMurry-Heath Michelle · CIK 0001904156 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,773 F1 · shares: The Reporting Person was granted restricted stock units, with each unit representing a contingent right to receive one share of the issuer's common stock. The grant of restricted stock units will fully vest on April 22, 2025, the scheduled date for the issuer's next annual meeting of shareholders, subject to the reporting person's continued service through such date or, if earlier, upon the reporting person's death, disability or qualifying retirement, or the termination of the reporting person's service within 12 months following a change in control. Read SEC document |
| June 16, 2023 Filed Jun 20, 2023 21:21 UTC | Bioventus Inc. BVS · Entity 4996 | Exercise / conversionRestricted Stock Units · Derivative | 386 | $0.00 | $0.00 |
DisclosureSEC source: 0001578563-23-000050 · primary_doc.xml · derivative · entry 2 McMurry-Heath Michelle · CIK 0001904156 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 386 Underlying: Class A Common Stock · 386 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: 386 RSUs vested on June 16, 2023. The remaining 386 RSUs shall vest and become exercisable on June 16, 2024, subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date. F2 · derivative.expiration_date: 386 RSUs vested on June 16, 2023. The remaining 386 RSUs shall vest and become exercisable on June 16, 2024, subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date. Read SEC document |
| June 16, 2023 Filed Jun 20, 2023 21:21 UTC | Bioventus Inc. BVS · Entity 4996 | Exercise / conversionClass A Common Stock | 386 | $0.00 | $0.00 |
DisclosureSEC source: 0001578563-23-000050 · primary_doc.xml · nonDerivative · entry 1 McMurry-Heath Michelle · CIK 0001904156 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,419 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 07, 2023 Filed Jun 8, 2023 23:21 UTC | Bioventus Inc. BVS · Entity 4996 | GrantRestricted Stock Units · Derivative | 30,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001578563-23-000040 · primary_doc.xml · derivative · entry 3 McMurry-Heath Michelle · CIK 0001904156 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,400 Underlying: Class A Common Stock · 30,400 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock. F3 · derivative.exercise_date: The RSUs shall vest and become exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first Annual Meeting of Stockholders following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date. F3 · derivative.expiration_date: The RSUs shall vest and become exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first Annual Meeting of Stockholders following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date. Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 23:21 UTC | Bioventus Inc. BVS · Entity 4996 | Exercise / conversionRestricted Stock Units · Derivative | 16,648 | $0.00 | $0.00 |
DisclosureSEC source: 0001578563-23-000040 · primary_doc.xml · derivative · entry 2 McMurry-Heath Michelle · CIK 0001904156 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 16,648 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The RSUs vested on June 6, 2023. F2 · derivative.expiration_date: The RSUs vested on June 6, 2023. Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 23:21 UTC | Bioventus Inc. BVS · Entity 4996 | Exercise / conversionClass A Common Stock | 16,648 | $0.00 | $0.00 |
DisclosureSEC source: 0001578563-23-000040 · primary_doc.xml · nonDerivative · entry 1 McMurry-Heath Michelle · CIK 0001904156 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,033 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 15, 2023 Filed May 17, 2023 20:06 UTC | REVVITY, INC. RVTY · Entity 3382 | GrantCommon Stock | 955 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-23-022712 · ownership.xml · nonDerivative · entry 2 McMurry-Heath Michelle · CIK 0001904156 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,796 Read SEC document |
| May 15, 2023 Filed May 17, 2023 20:06 UTC | REVVITY, INC. RVTY · Entity 3382 | GrantCommon Stock | 783 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-23-022712 · ownership.xml · nonDerivative · entry 1 McMurry-Heath Michelle · CIK 0001904156 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,841 F1 · shares: The reporting person was granted restricted stock units, with each unit representing a contingent right to receive one share of the issuer's common stock. The grant of restricted stock units will fully vest on April 23, 2024, the scheduled date for the issuer's next annual meeting of shareholders, subject to the reporting person's continued service through such date or, if earlier, upon the reporting person's death, disability or qualifying retirement, or the termination of the reporting person's service within 12 months following a change in control. Read SEC document |
| August 15, 2022 Filed Aug 17, 2022 20:05 UTC | REVVITY, INC. PKI · Entity 3382 | GrantCommon Stock | 581 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-028972 · doc4.xml · nonDerivative · entry 2 McMurry-Heath Michelle · CIK 0001904156 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,058 Read SEC document |
| August 15, 2022 Filed Aug 17, 2022 20:05 UTC | REVVITY, INC. PKI · Entity 3382 | GrantCommon Stock | 477 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-028972 · doc4.xml · nonDerivative · entry 1 McMurry-Heath Michelle · CIK 0001904156 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 477 F1 · shares: The reporting person was granted restricted stock units, with each unit representing a contingent right to receive one share of the issuer's common stock. The grant of restricted stock units will fully vest on April 25, 2023, the scheduled date for the issuer's next annual meeting of shareholders, subject to the reporting person's continued service through such date or, if earlier, upon the reporting person's death, disability or qualifying retirement, or the termination of the reporting person's service within 12 months following a change in control. Read SEC document |
| June 17, 2022 Filed Jun 23, 2022 00:39 UTC | Bioventus Inc. BVS · Entity 4996 | GrantRestricted Stock Units · Derivative | 16,648 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-023640 · doc4.xml · derivative · entry 3 McMurry-Heath Michelle · CIK 0001904156 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,648 Underlying: Class A Common Stock · 16,648 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock. F3 · derivative.exercise_date: The RSUs shall vest and become exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first Annual Meeting of stockholders following the date of grant and (ii) the first anniversary of the date of grant, subject to the Non-Employee Director continuing in service on the Issuer's Board of Directors through the applicable vesting date. F3 · derivative.expiration_date: The RSUs shall vest and become exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first Annual Meeting of stockholders following the date of grant and (ii) the first anniversary of the date of grant, subject to the Non-Employee Director continuing in service on the Issuer's Board of Directors through the applicable vesting date. Read SEC document |
| June 16, 2022 Filed Jun 23, 2022 00:39 UTC | Bioventus Inc. BVS · Entity 4996 | Exercise / conversionRestricted Stock Units · Derivative | 385 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-023640 · doc4.xml · derivative · entry 2 McMurry-Heath Michelle · CIK 0001904156 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 772 Underlying: Class A Common Stock · 385 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The remaining RSUs shall vest and become exercisable in two approximately equal installments on June 16, 2023 and June 16, 2024, subject to the Non-Employee Director continuing in service on the Issuer's Board of Directors through the applicable vesting date. F2 · derivative.expiration_date: The remaining RSUs shall vest and become exercisable in two approximately equal installments on June 16, 2023 and June 16, 2024, subject to the Non-Employee Director continuing in service on the Issuer's Board of Directors through the applicable vesting date. Read SEC document |
| June 16, 2022 Filed Jun 23, 2022 00:39 UTC | Bioventus Inc. BVS · Entity 4996 | Exercise / conversionClass A common stock | 385 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-023640 · doc4.xml · nonDerivative · entry 1 McMurry-Heath Michelle · CIK 0001904156 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 385 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 01, 2022 Filed Jan 12, 2022 21:10 UTC | Bioventus Inc. BVS · Entity 4996 | GrantRestricted Stock Units · Derivative | 1,157 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-001750 · doc4.xml · derivative · entry 1 McMurry-Heath Michelle · CIK 0001904156 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,157 Underlying: Class A Common Stock · 1,157 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock units shall vest and become exercisable in three equal installments, with the first installment vesting and becoming exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first annual meeting of stockholders following the date of grant and (ii) the first anniversary of the date of grant (such earlier date, the "Installment Vesting Date") and the second and third installments vesting and becoming exercisable on the first and second anniversaries of the Installment Vesting Date, respectively, in each case subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date. F2 · derivative.expiration_date: The restricted stock units shall vest and become exercisable in three equal installments, with the first installment vesting and becoming exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first annual meeting of stockholders following the date of grant and (ii) the first anniversary of the date of grant (such earlier date, the "Installment Vesting Date") and the second and third installments vesting and becoming exercisable on the first and second anniversaries of the Installment Vesting Date, respectively, in each case subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.